Skin Cancer/Melanoma

From Jason Kelce honoring the team trainer who has been diagnosed with cancer to deaths in the sports reporting and music world, here’s what’s happening in the oncology space this week.

February brought in multiple FDA approvals in the oncology space. Here’s an overview of some of the most recent ones.

Treatment with Amtagvi, a TIL therapy recently approved for advanced melanoma, includes a three-week hospital stay upfront, but may lead to years of monitoring without more treatment needed, an expert explained.

Personalized cancer vaccines are on the horizon and could be available for some patient populations as soon as next year, one expert said.

The Food and Drug Administration approved Amtagvi, a TIL therapy, for patients with advanced melanoma whose disease progressed on or after a checkpoint inhibitor and targeted therapy.

Moderna and Merck have initiated V940-001, a phase 3 study evaluating vaccine mRNA-4157 and anti-PD-1 therapy Keytruda as postsurgical treatment for stage 2B to 4 melanoma.

From the San Francisco 49ers’ Trent Williams looking back on his cancer experience to a Republican congressman returning to work after myeloma treatment, here’s what’s happening in the oncology space this week.

Substance use disorders, such as alcohol use disorder, were found to be more prevalent among survivors of specific cancer types, according to research.

From the Duchess of York receiving a skin cancer diagnosis to Selena Gomez contacting a fan with stage 4 disease, here’s what is happening in the oncology space this week.

Some with metastatic cancers receiving end-of-life-initiated immunotherapy may have a decreased risk of mortality when treated at a high-volume facility, research found.

Vd1-gd T cells, a rare type of immune cell, have been found to potentially predict how likely it is that certain patients with advanced skin cancer will be responsive to treatment via immunotherapy, according to recently published research.

A patient in a phase 2 trial has received the first dose of a novel cancer vaccine plus Keytruda for solid skin cancer tumors.

From Jimmy Buffett's death to the chemo shortage and cannabis use in cancer care, here is a look back at some of our most popular oncology stories from 2023.

As ‘Big Bang Theory’ star Kate Micucci announced that she is cancer-free and ‘Married at First Sight’ dating coach Mel Schilling announced her cancer diagnosis, here is what’s happening in the oncology space this week.

The Food and Drug Administration recently approved treatment for some patients with neuroblastoma, kidney cancer and bladder cancer. Elsewhere, a cancer vaccine made headlines for the treatment of patients with melanoma.

Patients with advanced-stage melanoma continue to experience reduced risk of recurrence or death following treatment with a combination of mRNA vaccine mRNA-4157 (V940) and Keytruda, an anti-PD-1 therapy, according to recent study findings.

As Billy Bean, MLB VP, revealed a cancer diagnosis and Toronto Blue Jays sportscaster, Jamie Campbell showed pre-skin cancer photo, here is what’s happening in the oncology space this week.

The Food and Drug Administration gave the green light to a phase 1/2 trial of KSQ-001EX for patients with melanoma, head and neck squamous cell carcinoma and non-small cell lung cancer.

In honor of National Family Caregiver’s Month, CURE® highlights some of the most important news in 2023.

An expert reflects on the recent FDA approval of adjuvant Opdivo for patients with stage 2B or 2C melanoma.

A phase 2 study evaluated meaningful activity from lifileucel for patients with advanced mucosal melanoma who experienced disease progression on immune checkpoint inhibitors.

The FDA approved Opdivo for the treatment of patients aged 12 years and older with stage 2B or 2C melanoma that has been surgically removed

A diagnosis of a rare internal form of melanoma left J.B. Ward and her care team in “a whirlwind of confusion,” but she pushed for aggressive forms of treatment.